However, the possible beneficial effects of IGF-I on cortical responses may be altered in pathological situations in which the circulating IGF-I signaling is decreased, such as diabetes or Alzheimer’s disease [2,25]. This evidence concerns the gene IGF1 and diabetes mellitus.